APA (7th ed.) Citation

BA, S., JR, S., L, M., A, M., R, B., F, O., . . . AA, G. (2018). VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatric blood & cancer, 65(1), . https://doi.org/10.1002/pbc.26728

Chicago Style (17th ed.) Citation

BA, Setty, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, and Gupta AA. "VIncristine, Irinotecan, and Temozolomide in Children and Adolescents with Relapsed Rhabdomyosarcoma." Pediatric Blood & Cancer 65, no. 1 (2018). https://doi.org/10.1002/pbc.26728.

MLA (9th ed.) Citation

BA, Setty, et al. "VIncristine, Irinotecan, and Temozolomide in Children and Adolescents with Relapsed Rhabdomyosarcoma." Pediatric Blood & Cancer, vol. 65, no. 1, 2018, https://doi.org/10.1002/pbc.26728.